N-(2,3-diphenyl-1,2,4-thiadiazol-5(2H)-ylidene)methanamine hydrobromide

ID: ALA3913449

Max Phase: Preclinical

Molecular Formula: C15H14BrN3S

Molecular Weight: 267.36

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Br.C/N=c1\nc(-c2ccccc2)n(-c2ccccc2)s1

Standard InChI:  InChI=1S/C15H13N3S.BrH/c1-16-15-17-14(12-8-4-2-5-9-12)18(19-15)13-10-6-3-7-11-13;/h2-11H,1H3;1H/b16-15+;

Standard InChI Key:  YJYGOWVFDGULLL-GEEYTBSJSA-N

Molfile:  

     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
   16.2458  -11.3959    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   12.9566  -11.9036    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.7399  -12.6997    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4300  -13.1518    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   14.0734  -12.6351    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.7807  -11.8638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2292  -11.1744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0541  -11.2223    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5062  -10.5329    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1345   -9.7951    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3061   -9.7509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8578  -10.4413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8688  -12.8495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0783  -13.6489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.8737  -13.8658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4604  -13.2843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2463  -12.4829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4513  -12.2698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9682  -12.9922    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.3290  -12.4703    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  2  2  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  6  7  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 13  1  0
  5 13  1  0
  3 19  2  0
 19 20  1  0
M  END

Associated Targets(Human)

DDAH1 Tchem N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 (231 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 267.36Molecular Weight (Monoisotopic): 267.0830AlogP: 3.13#Rotatable Bonds: 2
Polar Surface Area: 30.18Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.13CX LogP: 3.99CX LogD: 3.99
Aromatic Rings: 3Heavy Atoms: 19QED Weighted: 0.70Np Likeness Score: -0.75

References

1.  (2014)  Dimethylarginine Dimethylaminohydrolase inhibitors and methods of use thereof, 

Source